Sanofi, FR0000127771

Sanofi stock heads into the open after a 2.3 percent Paris gain

Published on 09/16/2026 at 08:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 14, 2026, Sanofi stock finished at EUR 74.96 on Euronext Paris, up 2.32 percent, with the shares trading between EUR 73.15 and EUR 75.20. Today, investors watch Sanofi stock after its appearance at a major healthcare conference.

Fotorealistisches TV-Studio mit Kameras, Lichtern und Nachrichtendesk in Paris
Vivendi SE (FR0000127771) betreibt Medienstudios; dieses Bild zeigt ein realistisches TV-Studio mit Kameratechnik und Regie, Illustration mit AI erstellt.

Sanofi stock closed at EUR 74.96 on Euronext Paris on September 14, 2026, gaining 2.32 percent from the prior session. The move left the shares near the EUR 75 mark and roughly in line with recent commentary that has focused on valuation and earnings power.

September 14, 2026 in numbers

Sanofi SA (ISIN FR0000127771, Euronext Paris: SAN) finished the September 14, 2026 session at EUR 74.96 on Euronext Paris after trading between an intraday low near EUR 73.15 and a high around EUR 75.20, with the close sitting comfortably within that range. Per exchange data, the daily gain of 2.32 percent reflected a firm rebound against the previous close, while the broader Euro Stoxx 50 index showed a more moderate advance on the same date, underscoring that Sanofi outperformed its regional blue-chip benchmark that day. A recent valuation-focused article on Sanofi published by Yahoo Finance on September 15, 2026 noted a share price around EUR 75.43 and discussed whether that level is justified by the group’s earnings power, indicating that investors remain focused on the balance between growth prospects and current pricing. In parallel, The Globe and Mail reported on September 15, 2026 that Deutsche Bank reaffirmed its buy rating on Sanofi with a price target of EUR 95.00, providing a supportive analyst backdrop in the wake of the latest session.

Conference follow-up today

Looking ahead to today, one focal point for Sanofi is its participation in the Morgan Stanley 24th Annual Global Healthcare Conference, with a presentation dated September 15, 2026 according to a transcript carried by MarketScreener. Investors may weigh any strategic or pipeline commentary from that appearance as trading resumes today on Euronext Paris. In addition, the reaffirmed buy rating and EUR 95.00 price target from Deutsche Bank, highlighted by The Globe and Mail, remains a reference point for sentiment as the stock heads into the open today.

Disclaimer...

en | FR0000127771 | SANOFI | boerse | 70109333 | bgmi